Celadon Pharmaceuticals Secures £30k Series C+ Funding at £300m Valuation
London-based Celadon Pharmaceuticals Limited has completed a £30k Series C+ funding round, achieving an estimated post-money valuation of £300m. The allotment, filed on 17 February 2026 following an i...